SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* FERNANDES CONRAD J (Last) (First) (Middle) TELEDYNE LECROY, INC. 700 CHESTNUT RIDGE ROAD (Street) CHESTNUT RIDGE NY 10977 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Teledyne LeCroy, Inc. [ LCRY ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Vice President
	3. Date of Earliest Transaction (Month/Day/Year) 08/03/2012
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/03/2012		D		5,332	D	$14.3(1)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Right	$7.6	08/03/2012		D			18,000	(2)	(3)	Common Stock	18,000	(4)	0	D
Stock Appreciation Right	$8.06	08/03/2012		D			121,000	(5)	(6)	Common Stock	121,000	(7)	0	D
Stock Appreciation Right	$4.07	08/03/2012		D			62,250	(8)	(9)	Common Stock	62,250	(10)	0	D
Stock Appreciation Right	$8.82	08/03/2012		D			50,000	(11)	(12)	Common Stock	50,000	(13)	0	D

Explanation of Responses:

1. Disposed of for a cash payment pursuant to the agreement and plan of merger by and among LeCroy Corporation, Teledyne Technologies Incorporated, and Luna Merger Sub, Inc. (the "Merger Agreement").

2. 3,000 SARs were exercisable on 8/21/10 and 15,000 SARs were exercisable on 8/21/11.

3. 3,000 SARs expire on 8/21/14 and 15,000 SARs expire on 8/21/15.

4. The SARs, which were vested, were converted in the Merger Agreement into the right to receive a cash payment equal to $6.70 per share (representing the difference between the base price of the SAR and the merger consideration of $14.30).

5. 30,250 SARs were exercisable on 8/8/09, 30,250 SARS were exercisable on 8/8/10, 30,250 SARs were exercisable on 8/8/11, and 30,250 SARs were exercisable on 8/8/12.

6. 30,250 SARs expire on 8/8/13, 30,250 SARS expire on 8/8/14, 30,250 SARs expire on 8/8/15, and 30,250 SARs expire on 8/8/16.

7. The SARs, of which 90,750 were vested and 30,250 were unvested, were converted in the Merger Agreement into the right to receive a cash payment equal to $6.24 per share (representing the difference between the base price of the SAR and the merger consideration of $14.30).

8. 20,750 SARs were exercisable on 5/29/11, 20,750 SARS were exercisable on 5/29/12, and 20,750 SARs were exercisable on 5/29/13.

9. 20,750 SARs expire on 5/29/15, 20,750 SARS expire on 5/29/16, and 20,750 SARs expire on 5/29/17.

10. The SARs, of which 41,500 were vested and 20,750 were unvested, were converted in the Merger Agreement into the right to receive a cash payment equal to $10.23 per share (representing the difference between the base price of the SAR and the merger consideration of $14.30).

11. 12,500 SARs were exercisable on 8/17/12, 12,500 SARS were exercisable on 8/17/13, 12,500 SARs were exercisable on 8/17/14, and 12,500 SARs were exercisable on 8/17/15.

12. 12,500 SARs expire on 8/17/16, 12,500 SARS expire on 8/17/17, 12,500 SARs expire on 8/17/18, and 12,500 SARs expire on 8/17/19.

13. The SARs, which were unvested, were converted in the Merger Agreement into the right to receive a cash payment equal to $5.48 per share (representing the difference between the base price of the SAR and the merger consideration of $14.30).

	/s/ Conrad J Fernandes	08/07/2012
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.